CDNA 29.26 (-2.86%)
US14167L1035Medical Diagnostics & ResearchDiagnostics & Research

CareDx (CDNA) Competitor Comparison

We are evaluating the key criteria listed to compare CareDx (CDNA) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - CDNA ranking 38 / 58

These are the competitors of CareDx in the industry Diagnostics & Research ranked by linearity 3 years
1. Natera NTRA
878.48
2. Quest Diagnostics DGX
718.46
3. Thermo Fisher Scientific TMO
77.18
4. Danaher DHR
36.87
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. IQVIA Holdings IQV
26.48
7. Mettler-Toledo MTD
17.62
8. PerkinElmer PKI
16.14
9. Sera Prognostics SERA
16.05
10. Icon ICLR
15.04
11. Laboratory Corp of America Holdings LH
14.02
12. Qiagen QGEN
12.61
13. Syneos Health SYNH
10.68
14. Waters WAT
9.95
15. Agilent Technologies A
8.43
16. Myriad Genetics MYGN
8.32
17. Heska HSKA
7.67
18. IDEXX Laboratories IDXX
7.05
19. Olink Holding OLK
6.67
20. Bioventus BVS
6.02
21. Anixa Biosciences ANIX
5.79
22. Sotera Health SHC
4.9
23. Trinity Biotech TRIB
4.75
24. DexCom DXCM
4.36
25. Global Cord Blood CO
4.22
26. Exact Sciences EXAS
4.03
27. National Research NRC
4
28. Charles River Laboratories CRL
3.03
29. Psychemedics PMD
2.84
30. Neogen NEOG
2.77
31. Enzo Biochem ENZ
2.62
32. Illumina ILMN
2.36
33. Fulgent Genetics FLGT
2.22
34. MDxHealth MDXH
2.13
35. MaxCyte MXCT
2.09
36. Twist Bioscience TWST
2.08
37. NeoGenomics NEO
2.06
38. CareDx CDNA
2.06
39. Neuronetics STIM
1.98
40. Medpace Holdings MEDP
1.96
41. Guardant Health GH
1.84
42. DarioHealth DRIO
1.79
43. Organovo Holdings ONVO
1.79
44. Inotiv NOTV
1.78
45. Co-Diagnostics CODX
1.77
46. Prenetics Global PRE
1.77
47. bioAffinity Technologies BIAF
1.77
48. Exagen XGN
1.76
49. Interpace Biosciences IDXG
1.72
50. Pacific Biosciences of California PACB
1.68
51. Biodesix BDSX
1.66
52. Precipio PRPO
1.6
53. Personalis PSNL
1.57
54. SeqLL SQL
1.5
55. Aspira Womens Health AWH
1.38
56. Meridian Bioscience VIVO
0.73
57. Lantheus Holdings LNTH
0.68
58. RadNet RDNT
0.62

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.